BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34879794)

  • 21. Differential roles for lysyl oxidase (like), family members in chronic obstructive pulmonary disease; from gene and protein expression to function.
    Migulina N; Tjin G; Faiz A; Borghuis T; Zhao F; Kaper HJ; Metzlar M; van Dijk E; Sharma PK; Timens W; Gosens R; Brandsma CA; Burgess JK
    FASEB J; 2022 Jul; 36(7):e22374. PubMed ID: 35670745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of lysyl oxidases LOXL1 and LOX during growth and aging suggests specific roles in elastin and collagen fiber remodeling in rat aorta.
    Behmoaras J; Slove S; Seve S; Vranckx R; Sommer P; Jacob MP
    Rejuvenation Res; 2008 Oct; 11(5):883-9. PubMed ID: 18803461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysyl Oxidases Expression and Breast Cancer Progression: A Bioinformatic Analysis.
    Ramos S; Ferreira S; Fernandes AS; Saraiva N
    Front Pharmacol; 2022; 13():883998. PubMed ID: 35800439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human lysyl oxidase-like 2.
    Moon HJ; Finney J; Ronnebaum T; Mure M
    Bioorg Chem; 2014 Dec; 57():231-241. PubMed ID: 25146937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysyl oxidases in mammalian development and certain pathological conditions.
    Mäki JM
    Histol Histopathol; 2009 May; 24(5):651-60. PubMed ID: 19283672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer.
    Trackman PC
    Expert Opin Ther Targets; 2016 Aug; 20(8):935-45. PubMed ID: 26848785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
    Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z
    Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
    Tanji N; Markowitz GS; Fu C; Kislinger T; Taguchi A; Pischetsrieder M; Stern D; Schmidt AM; D'Agati VD
    J Am Soc Nephrol; 2000 Sep; 11(9):1656-1666. PubMed ID: 10966490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung.
    Ma HY; Li Q; Wong WR; N'Diaye EN; Caplazi P; Bender H; Huang Z; Arlantico A; Jeet S; Wong A; Emson C; Brightbill H; Tam L; Newman R; Roose-Girma M; Sandoval W; Ding N
    Sci Adv; 2023 May; 9(21):eadf0133. PubMed ID: 37235663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysyl oxidase expression and collagen cross-linking during chronic adriamycin nephropathy.
    Di Donato A; Ghiggeri GM; Di Duca M; Jivotenko E; Acinni R; Campolo J; Ginevri F; Gusmano R
    Nephron; 1997; 76(2):192-200. PubMed ID: 9200411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the lysyl oxidases in tumour desmoplasia.
    Chitty JL; Setargew YFI; Cox TR
    Biochem Soc Trans; 2019 Dec; 47(6):1661-1678. PubMed ID: 31754702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reciprocal regulation of LOX and LOXL2 expression during cell adhesion and terminal differentiation in epidermal keratinocytes.
    Fujimoto E; Tajima S
    J Dermatol Sci; 2009 Aug; 55(2):91-8. PubMed ID: 19394199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis.
    Aumiller V; Strobel B; Romeike M; Schuler M; Stierstorfer BE; Kreuz S
    Sci Rep; 2017 Mar; 7(1):149. PubMed ID: 28273952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation.
    Iftikhar M; Hurtado P; Bais MV; Wigner N; Stephens DN; Gerstenfeld LC; Trackman PC
    J Biol Chem; 2011 Jan; 286(2):909-18. PubMed ID: 21071451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.
    Cosgrove D; Dufek B; Meehan DT; Delimont D; Hartnett M; Samuelson G; Gratton MA; Phillips G; MacKenna DA; Bain G
    Kidney Int; 2018 Aug; 94(2):303-314. PubMed ID: 29759420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disulfiram prevents collagen crosslinking and inhibits renal fibrosis by inhibiting lysyl oxidase enzymes.
    Saifi MA; Shaikh AS; Kaki VR; Godugu C
    J Cell Physiol; 2022 May; 237(5):2516-2527. PubMed ID: 35285015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor-beta induces extracellular matrix protein cross-linking lysyl oxidase (LOX) genes in human trabecular meshwork cells.
    Sethi A; Mao W; Wordinger RJ; Clark AF
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5240-50. PubMed ID: 21546528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the Interplay between Polyphenols and Lysyl Oxidase Enzymes for Maintaining Extracellular Matrix Homeostasis.
    Añazco C; Riedelsberger J; Vega-Montoto L; Rojas A
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.